| 0.6902 0.06 (9.56%) | 03-10 16:00 | |||||||||||||
|
|
| Short term | |
|||
| Mid term | |
|||
| Targets | 6-month : | 0.86 | 1-year : | 1 |
| Resists | First : | 0.74 | Second : | 0.86 |
| Pivot price | 0.63 |
|||
| Supports | First : | 0.58 | Second : | 0.49 |
| MAs | MA(5) : | 0.62 |
MA(20) : | 0.61 |
| MA(100) : | 0.78 |
MA(250) : | 1.34 |
|
| MACD | MACD : | 0 |
Signal : | -0.1 |
| %K %D | K(14,3) : | 59.6 |
D(3) : | 48.3 |
| RSI | RSI(14): 61.2 |
|||
| 52-week | High : | 4.17 | Low : | 0.49 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.[ CAPS ] has closed below upper band by 11.5%. Bollinger Bands are 18.5% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 0.73 - 0.73 | 0.73 - 0.74 |
| Low: | 0.52 - 0.53 | 0.53 - 0.53 |
| Close: | 0.71 - 0.72 | 0.72 - 0.72 |
Capstone Therapeutics Corp., a biotechnology company, develops novel peptides and other molecules for helping patients with under-served medical conditions in the United States. It develops Apo E mimetic peptide molecule AEM-28 and its analogs that have completed Phase Ia and Phase Ib/IIa clinical trials for lipoprotein metabolism. The company was formerly known as OrthoLogic Corp. and changed its name to Capstone Therapeutics Corp. in May 2010. Capstone Therapeutics Corp. was founded in 1987 and is headquartered in Tempe, Arizona.
Tue, 10 Mar 2026
12 Industrials Stocks Moving In Tuesday's Pre-Market Session - Benzinga
Tue, 10 Mar 2026
Capstone Expands Retail Portfolio as Order Volume Accelerates; Contractor Demand Drives Repeat Revenue and EBITDA Growth - Business Wire
Tue, 03 Mar 2026
Capstone Secures New Homebuilder Projects Adding Immediate Revenue and EBITDA Growth - guardonline.com
Tue, 03 Mar 2026
Big builders tap AI-powered distributor Capstone for 300K sq ft in projects - Stock Titan
Tue, 03 Feb 2026
Capstone Positioned to Benefit as Small-Cap Stocks Lead Early 2026 Markets - ACCESS Newswire
Wed, 21 Jan 2026
Capstone Holding (CAPS) Launches $2M Cost-Cutting Program Aiming for Positive Free Cash Flow - Intellectia AI
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Basic Materials
|
|
|
Industry:
Construction Materials
|
|
| Shares Out | 9 (M) |
| Shares Float | 5 (M) |
| Held by Insiders | 38.1 (%) |
| Held by Institutions | 1.4 (%) |
| Shares Short | 150 (K) |
| Shares Short P.Month | 54 (K) |
| EPS | -8.66 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 3.99 |
| Profit Margin | -12.4 % |
| Operating Margin | -5.7 % |
| Return on Assets (ttm) | -3.2 % |
| Return on Equity (ttm) | -20.3 % |
| Qtrly Rev. Growth | 10.8 % |
| Gross Profit (p.s.) | 1.07 |
| Sales Per Share | 4.91 |
| EBITDA (p.s.) | -0.26 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -1 (M) |
| Levered Free Cash Flow | -2 (M) |
| PE Ratio | -0.09 |
| PEG Ratio | 0 |
| Price to Book value | 0.17 |
| Price to Sales | 0.14 |
| Price to Cash Flow | -5.17 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |